The amylin analog pramlintide improves glycemic control and reduces postprandial glucagon concentrations in patients with type 1 diabetes mellitus (Q57632250)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 July 1999

Language	Label	Description	Also known as
English	The amylin analog pramlintide improves glycemic control and reduces postprandial glucagon concentrations in patients with type 1 diabetes mellitus	scientific article published on 01 July 1999

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10421239%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

The amylin analog pramlintide improves glycemic control and reduces postprandial glucagon concentrations in patients with type 1 diabetes mellitus (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10421239%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

type-1 diabetes

0 references

0 references

1 reference

based on heuristic

inferred from title

Claus H. Gravholt

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10421239%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10421239%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

author name string

B Nyholm

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10421239%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

L Orskov

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10421239%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

K Y Hove

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10421239%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

K G Alberti

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10421239%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

C Moyses

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10421239%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

O Kolterman

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10421239%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

O Schmitz

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10421239%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

publication date

1 July 1999

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10421239%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10421239%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

48

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10421239%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10421239%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

935-941

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10421239%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

Islet amyloid polypeptide response to glucose, insulin, and somatostatin analogue administration

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990232-9

7 January 2021

Reduction of Postprandial Hyperglycemia in Subjects With IDDM by Intravenous Infusion of AC137, a Human Amylin Analogue

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990232-9

7 January 2021

Effects of pramlintide, an analog of human amylin, on plasma glucose profiles in patients with IDDM: results of a multicenter trial

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990232-9

7 January 2021

Effects of 4 weeks' administration of pramlintide, a human amylin analogue, on glycaemia control in patients with IDDM: effects on plasma glucose profiles and serum fructosamine concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990232-9

7 January 2021

Lack of acute effect of amylin (islet associated polypeptide) on insulin sensitivity during hyperinsulinaemic euglycaemic clamp in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990232-9

7 January 2021

Infusion of pramlintide, a human amylin analogue, delays gastric emptying in men with IDDM

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990232-9

7 January 2021

Dose-responses for the slowing of gastric emptying in a rodent model by glucagon-like peptide (7-36) NH2, amylin, cholecystokinin, and other possible regulators of nutrient uptake

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990232-9

7 January 2021

Dose-response for glucagonostatic effect of amylin in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990232-9

7 January 2021

Glucagon physiology and pathophysiology

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990232-9

7 January 2021

Glucagon and its family revisited

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990232-9

7 January 2021

Contribution to postprandial hyperglycemia and effect on initial splanchnic glucose clearance of hepatic glucose cycling in glucose-intolerant or NIDDM patients

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990232-9

7 January 2021

The essential role of glucagon in the pathogenesis of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990232-9

7 January 2021

Glucagon: Role in the Hyperglycemia of Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990232-9

7 January 2021

Wick Chromatography for Rapid and Reliable Immunoassay of Insulin, Glucagon and Growth Hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990232-9

7 January 2021

Kinetics of HbA1c, glycated albumin, and fructosamine and analysis of their weight functions against preceding plasma glucose level

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990232-9

7 January 2021

Effect of 14 days' subcutaneous administration of the human amylin analogue, pramlintide (AC137), on an intravenous insulin challenge and response to a standard liquid meal in patients with IDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990232-9

7 January 2021

Hepatic and peripheral insulin resistance: a common feature of type 2 (non-insulin-dependent) and type 1 (insulin-dependent) diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990232-9

7 January 2021

Abnormal meal carbohydrate disposition in insulin-dependent diabetes. Relative contributions of endogenous glucose production and initial splanchnic uptake and effect of intensive insulin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990232-9

7 January 2021

Hyperglucagonemia and Blood Glucose Regulation in Normal, Obese and Diabetic Subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990232-9

7 January 2021

Persistent effect of sustained hyperglucagonemia on glucose production in man

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990232-9

7 January 2021

Evidence for an important role of changes in rather than absolute concentrations of glucagon in the regulation of glucose production in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990232-9

7 January 2021

Decreased hepatic glucagon responses in type 1 (insulin-dependent) diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990232-9

7 January 2021

Failure of glucagon suppression contributes to postprandial hyperglycaemia in IDDM

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990232-9

7 January 2021

Inhibitory effect of rat amylin on the insulin responses to glucose and arginine in the perfused rat pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990232-9

7 January 2021

In vitro autoradiographic localization of amylin binding sites in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990232-9

7 January 2021

Role of amylin in nutrient intake - animal studies

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990232-9

7 January 2021

Leptin: the tale of an obesity gene

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990232-9

7 January 2021

Effects of glucagon on free fatty acid metabolism in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990232-9

7 January 2021

Amylin injection causes elevated plasma lactate and glucose in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990232-9

7 January 2021

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990232-9

7 January 2021

Identifiers

10.1016/S0026-0495(99)90232-9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10421239%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10421239%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57632250&oldid=2154440157"